Trials / Withdrawn
WithdrawnNCT02656914
Efficacy and Safety of Irlanda-2 Association on the Treatment of Common Cold
Phase III, National, Multicenter, Randomized, Double-blind Clinical Trial to Evaluate the Efficacy and Safety of Irlanda-2 Association on the Treatment of Common Cold
- Status
- Withdrawn
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- EMS · Industry
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the clinical efficacy of the drug associations in the treatment of common cold
Detailed description
Double blind,randomized, multicenter; Maximal experiment duration: 7 days; 03 visits; Safety and efficacy evaluation
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Irlanda-2-Association | Take 10 mL every 12 hours (2x/day), oral route. |
| DRUG | Placebo | Take 10 mL every 12 hours (2x/day), oral route. |
Timeline
- Start date
- 2019-06-01
- Primary completion
- 2020-06-01
- Completion
- 2020-09-01
- First posted
- 2016-01-15
- Last updated
- 2019-10-16
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT02656914. Inclusion in this directory is not an endorsement.